Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 April 2024 | Story Lacea Loader | Photo Sonia Small
Prof John Klaasen, newly appointed Dean: Theology and Religion at the UFS
Prof John Klaasen, newly appointed Dean: Theology and Religion at the UFS.

The University of the Free State (UFS) has appointed Prof John Klaasen as Dean: Faculty of Theology and Religion from 1 April 2024. 

Prof Klaasen is Professor of Theology and has served two terms as Head of the Department of Religion and Theology at the University of the Western Cape. He also served as Professor in the Kjell Nordstokke Chair in Community Development at VID Specialized University in Norway and is Adjunct Professor at VID Specialized University. 

“With his vast experience and involvement in research projects – nationally as well as internationally – Prof Klaasen will make a significant contribution to the Faculty of Theology and Religion and the university in general. This will also be valuable in support of the university’s Vision 130, which is an expression of our strategic intent to position the institution towards 2034 when the UFS will be 130 years old,” says Prof Francis Petersen, Vice-Chancellor and Principal of the UFS.

As a practical theologian, the intersection between praxis and theory has occupied Prof Klaasen’s research for the past decade. He has researched and published extensively within theology, community development, and narrative. Aspects such as narrative, embedded knowledge, participation, reconciliation, and the non-rational tradition of knowledge are some of the areas that occupy his research outputs.

He is involved in numerous international research projects, which include a COST project with 17 European institutions, a project on reconciliation processes with institutions in Canada and Nordic countries, an international initiative on community development with various institutions in Europe, and a NORPART initiative with Norway and Malawi.

Community engaged scholarship forms a central part of his research and work at the intersection of religion and social justice. Prof Klaasen is involved in various community development projects, including homes for the aged, lay training, water issues, and lay theological education.

His teaching is situated within a socially just pedagogy, which puts the students at the centre of knowledge production. This innovative way of knowledge production intersects students, teachers, and the lecture room within a dynamic space of contextualisation.

“I am grateful for the opportunity to join such a prestigious institution and will endeavour to contribute to Vision 130 through commitment, innovation, trust, and ethical leadership – which represents the university’s commitment to be recognised by our peers and society as a top-tier university in South Africa, ranked among the best in the world,” says Prof Klaasen.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept